AR Scientific, Inc. Report issue

For profit Phase 3
Founded: Philadelphia PA United States (2004)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2007
NCT00506883
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

colchicine (colbenemid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Gout (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1